348 results
Complications in complex rotational atherectomy
This session will help you get prepared if you have to become familiar with a novel way to release stuck rotational atherectomy burr, deal with severely calcified RCA including removal of a stuck Rotablator, or cope when Rotablator burr catheter entraps.
Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial
18 Jun 2021
The HOST-EXAM trial sought to define whether, after DAPT for PCI with DES, clopidogrel monotherapy is associated with improved outcomes compared with aspirin monotherapy.
Reviewer
External applicability of the ISCHEMIA trial: an analysis of a prospective nationwide registry of patients with stable coronary artery disease
03 Jun 2021
This study aimed to delineate the external validity of the ISCHEMIA trial by applying the ISCHEMIA inclusion and exclusion criteria to an established cohort of patients with stable coronary disease in an observational setting.
Reviewer
Reviewer
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis
01 Jun 2021
The value of elective coronary revascularisation plus medical therapy over medical therapy alone in managing stable patients with coronary artery disease is debated. Hence, the authors reviewed all trials comparing the two strategies in this population to appraise whether revascularisation in addition to medical therapy affects...
Reviewer
Meta-analysis of elective coronary revascularization versus medical therapy alone - EuroPCR 2021 interview
27 May 2021 – From EuroPCR 2021
Luis Ortega Paz interviews Eliano Navarese, lead investigator of this meta-analysis of elective coronary revascularization versus medical therapy alone, released as a late-breaking trial at EuroPCR 2021:
- The gap in evidence that motivated this systematic review and meta-analysis
- The methodology employed
- The main findings
- How will these results impact clinical...
EuroPCR 2021 Hotlines / Late-Breaking Trials in physiology: FAST II, TARGET FFR, P3, OLV Pullback, France PCI, and more!
27 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in imaging:
- Angiography based Fractional Flow Reserve: the FAST II trial
- Instantaneous wave-free ratio for the assessment of nonculprit lesions
- Capacity of the PPG to predict functional revascularisation
- Clinical impact of FFR guided PCI
EuroPCR 2021 Hotlines / Late-Breaking Trials: Alster-FLX, ANGIE, COLOR, CREDENCE BRS, and P3
27 May 2021 – From EuroPCR 2021
Find out more about various studies & registries:
- Left atrial appendage occlusion with the WATCHMAN FLX: The Alster-FLX Registry
- Anatomical snuffbox for coronary angiography and interventions
- Randomized comparison between Radial and Femoral Large-bore access Complex PCI
- Experience with BRS for treatment of de novo native peripheral artery lesions
- Clinical validation of...
EuroPCR 2021 Hotlines / Late-Breaking Trials: PLA-pCi-EBO-pilot, CALM, ISCHEMIA, and more!
26 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in stable CAD:
- Effects of visualization of PCI results on symptoms in chronic coronary syndrome
- Effect of Atorvastatin Therapy on Serial Changes of Coronary Flow And Plaque
- Initial results of a feasibility study of endovascular baroreflex amplification in heart failure patients
- Impact...
EuroPCR 2021 Hotlines / Late-Breaking Trials in CT-based FFR: DISCOVER FLOW & P3
26 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in CT-based FFR:
- Ten-year outcomes of coronary lesions assessed by CT angiography derived FFR
- Accuracy of the FFRCT Planner in Complex Coronary Artery Disease
Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial
27 May 2021
ISCHEMIA-CKD is the only contemporary randomized trial that prospectively evaluated an upfront strategy of coronary angiography and revascularization plus optimal medical therapy (OMT) compared with OMT alone in patients listed for renal transplant.
Reviewer
